A real-world retrospective study of safety, efficacy, compliance and cost of combination treatment with rush immunotherapy plus one dose of pretreatment anti-IgE in Chinese children with respiratory allergies

BACKGROUND: The efficacy of allergen immunotherapy (AIT) in treating pediatric allergy has been clearly demonstrated, however, many patients hesitate to initiate AIT due to weekly hospital visits during the 3-4 months up-dosing phase. Meanwhile, rush immunotherapy (RIT) shortens the duration of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Pingping, Bian, Sainan, Wang, Xibin, Chen, Zhuanggui, Yang, Lifen, Xiao, Feng, Guan, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577550/
https://www.ncbi.nlm.nih.gov/pubmed/36268011
http://dx.doi.org/10.3389/fimmu.2022.1024319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577550/
https://www.ncbi.nlm.nih.gov/pubmed/36268011
http://dx.doi.org/10.3389/fimmu.2022.1024319

Ejemplares similares